In this study, we demonstrate for the first time that ex vivo expanded Tregs in PBMCs from CKD patients can suppress IFN-γ-producing Th1 cells and pathogenic IL-17A producing-Th17 cells by responder T cells. The gene discussed is IL17A; the disease is chronic kidney disease.